Foveal Sparing of the ILM
Launched by UNIVERSITÀ DEGLI STUDI DI BRESCIA · Mar 28, 2018
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • provision of written informed consent
- • age \> 60 years
- • presence of idiopathic macular pucker or macular hole documented by OCT
- Exclusion Criteria:
- • any prior intraocular surgery
- • pathologic myopia (\> 7 diopters)
- • age related macular degeneration
- • glaucoma and diabetic retinopathy or any other retinal vascular disease
About Università Degli Studi Di Brescia
Università degli Studi di Brescia is a prestigious academic institution in Italy, dedicated to advancing medical research and education. With a strong emphasis on innovation and interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving patient care and outcomes. Leveraging its extensive network of healthcare professionals and state-of-the-art facilities, the university fosters an environment conducive to groundbreaking research and the development of new therapeutic strategies. Through its commitment to scientific excellence and ethical standards, Università degli Studi di Brescia contributes significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials